VALENCIA, Calif., Feb. 21, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $16.7 million on February 17, 2017, upon closing the sale of real estate owned by the Company in Valencia, California, net of closing costs.
About MannKind Corporation
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
Company Contact: Rose Alinaya SVP, Finance 661-775-5300 [email protected]


Chinese Cars in Europe: Consumer Trust Is Shifting Fast
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



